Skip to main content
NCBI home page
Transactions of the American Ophthalmological Society logoLink to Transactions of the American Ophthalmological Society
. 1970;68:548–594.

Vitreoretinal changes in cicatricial retrolental fibroplasia.

W Tasman
PMCID: PMC1310390  PMID: 5538153

Full text

PDF
548

Images in this article

578FIGURE 18
on p.578
578FIGURE 19
on p.578
559FIGURE 2
on p.559
559FIGURE 3
on p.559
576FIGURE 15
on p.576
576FIGURE 16
on p.576
583FIGURE 24
on p.583
583FIGURE 25
on p.583
583FIGURE 26
on p.583
560FIGURE 4
on p.560
560FIGURE 5
on p.560
558FIGURE 1
on p.558
569FIGURE 6
on p.569
569FIGURE 7
on p.569
570FIGURE 8
on p.570
570FIGURE 9
on p.570
571FIGURE 10
on p.571
572FIGURE 11
on p.572
573FIGURE 12
on p.573
574FIGURE 13
on p.574
574FIGURE 14
on p.574
577FIGURE 17
on p.577
580FIGURE 20
on p.580
580FIGURE 21
on p.580
581FIGURE 22
on p.581
584FIGURE 27
on p.584
584FIGURE 28
on p.584

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHTON N. Animal experiments in retrolental fibroplasia. Trans Am Acad Ophthalmol Otolaryngol. 1954 Jan-Feb;58(1):51-3; discussion, 53-4. [PubMed] [Google Scholar]
  2. ASHTON N. Retinal vascularization in health and disease: Proctor Award Lecture of the Association for Research in Ophthalmology. Am J Ophthalmol. 1957 Oct;44(4 Pt 2):7–17. doi: 10.1016/0002-9394(57)90426-9. [DOI] [PubMed] [Google Scholar]
  3. ASHTON N., WARD B., SERPELL G. Role of oxygen in the genesis of retrolental fibroplasia; a preliminary report. Br J Ophthalmol. 1953 Sep;37(9):513–520. doi: 10.1136/bjo.37.9.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ashton N., Pedler C. STUDIES ON DEVELOPING RETINAL VESSELS: IX. REACTION OF ENDOTHELIAL CELLS TO OXYGEN. Br J Ophthalmol. 1962 May;46(5):257–276. doi: 10.1136/bjo.46.5.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BEDROSSIAN R. H., CARMICHAEL P., RITTER J. Retinopathy of prematurity (retrolental fibroplasia) and oxygen. I. Clinical study. II. Further observations on the disease. Am J Ophthalmol. 1954 Jan;37(1):78–86. doi: 10.1016/0002-9394(54)92034-6. [DOI] [PubMed] [Google Scholar]
  6. BEREZIN A., CAPOZZI A. ESTUDO COMPARATIVO DOS RESULTADOS DO TRATAMENTO DA HIPERBILIRRUBINEMIA DO REC'EMNASCIDO COM A LUZ FLUORESCENTE EM RELA C AO COM UM GRUPO CONTR OLE SEM TRATAMENTO. Matern Infanc (Sao Paulo) 1963 Oct-Dec;22:529–538. [PubMed] [Google Scholar]
  7. BRALEY A. E., OSTLER H. B. Statistics on 100 cases of retinal detachment surgery. J Iowa State Med Soc. 1955 Sep;45(9):473–476. [PubMed] [Google Scholar]
  8. CAMPBELL K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust. 1951 Jul 14;2(2):48–50. [PubMed] [Google Scholar]
  9. COGAN D. G. DEVELOPMENT AND SENESCENCE OF THE HUMAN RETINAL VASCULATURE. Trans Ophthalmol Soc U K. 1963;83:465–489. [PubMed] [Google Scholar]
  10. CREMER R. J., PERRYMAN P. W., RICHARDS D. H. Influence of light on the hyperbilirubinaemia of infants. Lancet. 1958 May 24;1(7030):1094–1097. doi: 10.1016/s0140-6736(58)91849-x. [DOI] [PubMed] [Google Scholar]
  11. CROSO E., DELASCIO D., GUARIENTO A. LA FOTOTERAPIA NELLA CURA DELLA MALATTIA EMOLITICA DEL NEONATO. Minerva Pediatr. 1964 Feb 11;16:131–134. [PubMed] [Google Scholar]
  12. CROSSE V. M., EVANS P. J. Prevention of retrolental fibroplasia. AMA Arch Ophthalmol. 1952 Jul;48(1):83–87. doi: 10.1001/archopht.1952.00920010086012. [DOI] [PubMed] [Google Scholar]
  13. DAY R. Kernicterus; further observations on the toxicity of heme pigments. Pediatrics. 1956 Jun;17(6):925–928. [PubMed] [Google Scholar]
  14. FERREIRA H. C., BEREZIN A., BARBIERI D., LARRUBIA M. N. [Super-illumination in hyperbilirubinemia in newborn infants]. J Pediatr (Rio J) 1960 Jan;25:12–14. [PubMed] [Google Scholar]
  15. FLETCHER M. C., BRANDON S. Myopia of prematurity. Am J Ophthalmol. 1955 Oct;40(4):474–481. doi: 10.1016/0002-9394(55)90548-1. [DOI] [PubMed] [Google Scholar]
  16. Friedenwald J. S., Owens W. C. Retrolental Fibroplasia in Premature Infants, III: The Pathology of the Disease. Trans Am Ophthalmol Soc. 1951;49:207–234. [PMC free article] [PubMed] [Google Scholar]
  17. Friedman E., Kuwabara T. The retinal pigment epithelium. IV. The damaging effects of radiant energy. Arch Ophthalmol. 1968 Aug;80(2):265–279. doi: 10.1001/archopht.1968.00980050267022. [DOI] [PubMed] [Google Scholar]
  18. GOMIRATOSANDRUCCI M., ANSALDI N., COLOMBO M. L. EFFETTO DELLA FOTOTERAPIA NELL'ITTERO NEONATALE DELL'IMMATURO. I. ITTERO FISIOLOGICO. Minerva Pediatr. 1965 Mar 3;17:394–399. [PubMed] [Google Scholar]
  19. GYLLENSTEN L. J., HELLSTROM B. E. Experimental approach to the pathogenesis of retrolental fibroplasia. II. The influence of the developmental maturity on oxygen-induced changes in the mouse eye. Am J Ophthalmol. 1955 Apr;39(4 Pt 1):475–488. [PubMed] [Google Scholar]
  20. GYLLENSTEN L. J., HELLSTROM B. E. Retrolental fibroplasia; animal experiments: the effect of intermittingly administered oxygen on the postnatal development of the eyes of fullterm mice. Acta Paediatr. 1952 Nov;41(6):577–582. doi: 10.1111/j.1651-2227.1952.tb17854.x. [DOI] [PubMed] [Google Scholar]
  21. Gorn R. A., Kuwabara T. Retinal damage by visible light. A physiologic study. Arch Ophthalmol. 1967 Jan;77(1):115–118. doi: 10.1001/archopht.1967.00980020117025. [DOI] [PubMed] [Google Scholar]
  22. HEATH P. Pathology of the retinopathy of prematurity: retrolental fibroplasia. Am J Ophthalmol. 1951 Sep;34(9):1249–1259. doi: 10.1016/0002-9394(51)91859-4. [DOI] [PubMed] [Google Scholar]
  23. HEPNER W. R., Jr, KRAUSE A. C. Retrolental fibroplasia: clinical observations. Pediatrics. 1952 Oct;10(4):433–443. [PubMed] [Google Scholar]
  24. HIATT R. L., COSTENBADER F. D., ALBERT D. G. CLINICAL EVALUATION OF CONGENITAL MYOPIA. Arch Ophthalmol. 1965 Jul;74:31–35. doi: 10.1001/archopht.1965.00970040033007. [DOI] [PubMed] [Google Scholar]
  25. JAEGER-LEE D. Oxygen control policies for premature infants in Georgia. J Med Assoc Ga. 1959 Jan;48(1):22–25. [PubMed] [Google Scholar]
  26. JEFFERSON E. Retrolental fibroplasia. Arch Dis Child. 1952 Aug;27(134):329–336. doi: 10.1136/adc.27.134.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. KING M. J. Retrolental fibroplasia; a clinical study of 238 cases. Arch Ophthal. 1950 Apr;43(4):694–711. [PubMed] [Google Scholar]
  28. Kalina R. E. Ophthalmic examination of children of low birth weight. Am J Ophthalmol. 1969 Jan;67(1):134–136. doi: 10.1016/0002-9394(69)90018-x. [DOI] [PubMed] [Google Scholar]
  29. Kuwabara T., Gorn R. A. Retinal damage by visible light. An electron microscopic study. Arch Ophthalmol. 1968 Jan;79(1):69–78. doi: 10.1001/archopht.1968.03850040071019. [DOI] [PubMed] [Google Scholar]
  30. LA MOTTE W. O., Jr, TYNER G. S., SCHEIE H. G. Treatment of retrolental fibroplasia with vitamin E, corticotropin (ACTH) and cortisone. AMA Arch Ophthalmol. 1952 May;47(5):556–569. doi: 10.1001/archopht.1952.01700030570002. [DOI] [PubMed] [Google Scholar]
  31. LANMAN J. T., GUY L. P., DANCIS J. Retrolental fibroplasia and oxygen therapy. J Am Med Assoc. 1954 May 15;155(3):223–226. doi: 10.1001/jama.1954.03690210001001. [DOI] [PubMed] [Google Scholar]
  32. LOCKE J. C., REESE A. B. Retrolental fibroplasia; the negative role of light, mydriatrics, and the ophthalmoscopic examination in its etiology. AMA Arch Ophthalmol. 1952 Jul;48(1):44–47. [PubMed] [Google Scholar]
  33. Lucey J., Ferriero M., Hewitt J. Prevention of hyperbilirubinemia of prematurity by phototherapy. Pediatrics. 1968 Jun;41(6):1047–1054. [PubMed] [Google Scholar]
  34. Noell W. K., Walker V. S., Kang B. S., Berman S. Retinal damage by light in rats. Invest Ophthalmol. 1966 Oct;5(5):450–473. [PubMed] [Google Scholar]
  35. OWENS W. C., OWENS E. U. Retrolental fibroplasia in premature infants; studies on the prophylaxis of the disease; the use of alpha tocopheryl acetate. Am J Ophthalmol. 1949 Dec;32(12):1631–1637. [PubMed] [Google Scholar]
  36. Orzalesi M. M., Mendicini M., Bucci G., Scalamandrè A., Savignoni P. G. Arterial oxygen studies in premature newborns with and without mild respiratory disorders. Arch Dis Child. 1967 Apr;42(222):174–180. doi: 10.1136/adc.42.222.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Owens W. C., Owens E. U. Retrolental Fibroplasia. Am J Public Health Nations Health. 1950 Apr;40(4):405–408. doi: 10.2105/ajph.40.4.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. PATZ A. Clinical and experimental studies on role of oxygen in retrolental fibroplasia. Trans Am Acad Ophthalmol Otolaryngol. 1954 Jan-Feb;58(1):45–50. [PubMed] [Google Scholar]
  39. PATZ A., EASTHAM A., HIGGINBOTHAM D. H., KLEH T. Oxygen studies in retrolental fibroplasia. II. The production of the microscopic changes of retrolental fibroplasia in experimental animals. Am J Ophthalmol. 1953 Nov;36(11):1511–1522. [PubMed] [Google Scholar]
  40. PATZ A., HOECK L. E., DE LA CRUZ E. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol. 1952 Sep;35(9):1248–1253. doi: 10.1016/0002-9394(52)91140-9. [DOI] [PubMed] [Google Scholar]
  41. PELUFFO E., BELTRAN J. C., MALINGER A., GIGUENS W., VILA VIDAL P., LORENZO Y DE IBARRETA J., GOLDARACENA C. [Light therapy in jaundices in the newborn]. Arch Pediatr Urug. 1962 Feb;33:98–105. [PubMed] [Google Scholar]
  42. Patz A. New role of the ophthalmologist in prevention of retrolental fibroplasia. Arch Ophthalmol. 1967 Nov;78(5):565–568. doi: 10.1001/archopht.1967.00980030567001. [DOI] [PubMed] [Google Scholar]
  43. Patz A. Oxygen administration to the premature infant. A two-edged sword. Am J Ophthalmol. 1967 Feb;63(2):351–353. doi: 10.1016/0002-9394(67)91567-x. [DOI] [PubMed] [Google Scholar]
  44. REESE A. B., BLODI F. C., LOCKE J. C. The pathology of early retrolental fibroplasia, with an analysis of the histologic findings in the eyes of newborn and stillborn infants. Am J Ophthalmol. 1952 Oct;35(10):1407–1426. [PubMed] [Google Scholar]
  45. REESE A. B., STEPANIK J. Cicatricial stage of retrolental fibroplasia. Am J Ophthalmol. 1954 Sep;38(3):308–316. doi: 10.1016/0002-9394(54)90846-6. [DOI] [PubMed] [Google Scholar]
  46. Roberton N. R., Gupta J. M., Dahlenburg G. W., Tizard J. P. Oxygen therapy in the newborn. Lancet. 1968 Jun 22;1(7556):1323–1329. doi: 10.1016/s0140-6736(68)92033-3. [DOI] [PubMed] [Google Scholar]
  47. SCHEPENS C. L. SYMPOSIUM: PRESENT STATUS OF RETINAL DETACHMENT SURGERY. SCLERAL BUCKLING WITH CIRCLING ELEMENT. Trans Am Acad Ophthalmol Otolaryngol. 1964 Nov-Dec;68:959–979. [PubMed] [Google Scholar]
  48. SHAPIRO S. Influence of birth weight, sex, and plurality on neonatal loss in United States. Am J Public Health Nations Health. 1954 Sep;44(9):1142–1153. doi: 10.2105/ajph.44.9.1142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. STRAATSMA B. R., ALLEN R. A. Lattice degeneration of the retina. Trans Am Acad Ophthalmol Otolaryngol. 1962 Sep-Oct;66:600–613. [PubMed] [Google Scholar]
  50. SWYER P. R., WRIGHT J. The control of supplemental oxygen by oximetry. Can Med Assoc J. 1958 Feb 15;78(4):231–235. [PMC free article] [PubMed] [Google Scholar]
  51. SZEWCZYK T. S. Retrolental fibroplasia: etiology and prophylaxis; a preliminary report. Am J Ophthalmol. 1951 Dec;34(12):1649–1650. doi: 10.1016/0002-9394(51)90028-1. [DOI] [PubMed] [Google Scholar]
  52. Silverman W. A. Oxygen therapy and retrolental fibroplasia. Am J Public Health Nations Health. 1968 Nov;58(11):2009–2011. doi: 10.2105/ajph.58.11.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. THOMSEN A. ARTERIAL BLOOD SAMPLING IN SMALL INFANTS. Acta Paediatr. 1964 May;53:237–240. doi: 10.1111/j.1651-2227.1964.tb07232.x. [DOI] [PubMed] [Google Scholar]
  54. TYNER G. S., FRAYER W. C. Clinical and autopsy findings in early retrolental fibroplasia; report of a case. AMA Arch Ophthalmol. 1951 Dec;46(6):647–654. doi: 10.1001/archopht.1951.01700020661005. [DOI] [PubMed] [Google Scholar]
  55. Thibeault D. W., Clutario B., Auld P. A. Arterial oxygen tension in premature infants. J Pediatr. 1966 Sep;69(3):449–451. doi: 10.1016/s0022-3476(66)80090-2. [DOI] [PubMed] [Google Scholar]
  56. Thibeault D. W., Poblete E., Auld P. A. Alevolar-arterial O2 and CO2 differences and their relation to lung volume in the newborn. Pediatrics. 1968 Mar;41(3):574–587. [PubMed] [Google Scholar]
  57. Thibeault D. W., Poblete E., Auld P. A. Alveolar-arterial oxygen difference in premature infants breathing 100 per cent oxygen. J Pediatr. 1967 Dec;71(6):814–824. doi: 10.1016/s0022-3476(67)80006-4. [DOI] [PubMed] [Google Scholar]
  58. UNSWORTH A. C. Retrolental fibroplasia or ophthalmic dysplasia of premature infants. Trans Am Ophthalmol Soc. 1949;47:738–771. [PMC free article] [PubMed] [Google Scholar]
  59. WARLEY M. A., GAIRDNER D. Respiratory distress syndrome of the newborn--principles in treatment. Arch Dis Child. 1962 Oct;37:455–465. doi: 10.1136/adc.37.195.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. ZACHARIAS L., REYNOLDS W. E., CHISHOLM J. F., Jr, KING M. J. The incidence and severity of retrolental fibroplasia in relation to possible causative factors. I. Observations on the occurrence of retrolental fibroplasia. II. Studies of the relationship of retrolental fibroplasia to degree of prematurity, oxygen therapy, general health, and date of birth of premature infants. Am J Ophthalmol. 1954 Sep;38(3):317–336. doi: 10.1016/0002-9394(54)90847-8. [DOI] [PubMed] [Google Scholar]
  61. ZACHARIAS L. Retrolental fibroplasia; a survey. Am J Ophthalmol. 1952 Oct;35(10):1426–1454. doi: 10.1016/0002-9394(52)92162-4. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society

RESOURCES